|
 
Saddle River, NJ – (July 6, 2006) PDI Performance Sales Teams, a leading provider of pharmaceutical sales and marketing personnel, has announced that Stephen Beckman, president and general manager at Exaeris, a specialty pharmaceutical sales and marketing company located in Exton, PA, is the winner of PDI’s Winning Performance Sweepstakes. Mr. Beckman was awarded the sweepstakes grand prize, valued at $5,000, of an all-expense paid trip to Paris to see the 2006 Tour de France.
Qualified pharmaceutical executives were able to enter the contest by visiting www.PerformanceSalesTeams.com before the deadline of May 31. Mr. Beckman was selected winner in a random drawing on June 2.
The sweepstakes was introduced concurrently with PDI Performance Sales Teams’ “Performance Driven!” marketing campaign and was publicized through advertising, direct mail, e-mail and the company’s website.
Speaking about the sweepstakes, Scott Stoogenke, PDI Executive Director of Marketing, said, “We watched Lance Armstrong challenge seemingly insurmountable odds to defeat cancer and then to win seven straight Tour de France races. What inherently drives this man — or any of us — to be a leader? Passion, commitment, focus and, most of all, performance. At PDI Performance Sales Teams, our mantra is ‘Performance Driven.’ We believe the only way to help clients be market leaders is to maximize their sales force ROI and give them the performance they need to win. So what better way to kick off our ‘Performance Driven’ campaign than with a trip to see the actual Tour de France?”
Open exclusively to pharmaceutical marketing executives in the United States, the sweepstakes was administered by Promotion Mechanics, Inc., of Newtown, CT.
For more information contact:
Stephen P. Cotugno
Executive Vice President-Corporate Development
PDI, Inc.
201-574-8617
About PDI
PDI, Inc. (NASDAQ: PDII) is a diversified sales and marketing services provider to the biopharmaceutical industry offering a comprehensive set of outsourced solutions for established and emerging pharmaceutical companies. PDI is dedicated to maximizing the return on investment for its clients by providing strategic flexibility; sales, marketing, and commercialization expertise; and a philosophy of performance.
Headquartered in Saddle River, NJ, PDI’s sales and marketing services include our Performance Sales Teams™, which are dedicated teams for specific clients, and Select Access™, our targeted sales solution that leverages an existing infrastructure. PDI also offers marketing research and consulting services through TVG in Dresher, PA, and medical communications services through Pharmakon in Schaumburg, IL. In addition, PDI is a high quality provider of ACCME-accredited continuing medical education through Vital Issues in Medicine (VIM ®) in Dresher, PA. The company’s experience extends across multiple therapeutic categories and includes office and hospital-based initiatives.
PDI’s commitment is to deliver innovative solutions, unparalleled execution and superior results for its clients. Through strategic partnership and client-driven innovation, PDI maintains some of the longest standing sales and marketing relationships in the industry. Recognized as an industry pioneer, PDI remains committed to continuous innovation and to maintaining the industry’s highest quality employees.
For more information, visit the Company’s website at www.pdi-inc.com.
For more information about PDI’s Performance Sales Teams, visit www.PerformanceSalesTeams.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding future events and financial performance. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control.
Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, changes in our operating expenses, adverse patent rulings, FDA, legal or accounting developments, competitive pressures, failure to meet performance benchmarks in significant contracts, changes in customer and market requirements and standards, the impact of
any stock repurchase programs, and the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2004, and PDI's periodic reports on Form 8-K filed with the Securities and Exchange Commission since January 1, 2005. The forward looking-statements in this press release are based upon
management's reasonable belief as of the date hereof. PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
|
